Information  X 
Enter a valid email address

ECO Animal Health (EAH)

  Print      Mail a friend

Tuesday 28 August, 2018

ECO Animal Health

Regulatory Approval

Regulatory Approval

Eco Animal Health Group Plc

ECO Animal Health Group plc

(AIM:EAH)

VIETNAM GRANTS ECO MARKETING AUTHORISATION FOR AIVLOSIN® FOR PIGS AND POULTRY

ECO Animal Health Group plc is pleased to announce that its subsidiary ECO Animal Health Limited (ECO) has received a marketing authorisation from the Department of Animal Health, Ministry of Agriculture and Rural Development, Vietnam for the use of Aivlosin® 625 mg/g water soluble granules in pigs and poultry.

Aivlosin®, ECO’s patented antimicrobial, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in pigs and poultry.

This authorisation allows ECO to start selling Aivlosin® in Vietnam for the medication of drinking water for the treatment and prevention of porcine proliferative enteropathy (PPE) caused by Lawsonia intracellularis in pigs, the treatment and prevention of respiratory disease associated with Mycoplasma gallisepticum in chickens and the treatment of respiratory disease in turkeys associated with Ornithobacterium rhinotracheale.

This license now allows ECO to submit the EU approved Aivlosin® regulatory files for the treatment of layers in Vietnam, the fourth largest egg producing country in Southeast Asia.

These new treatments meet all the latest guidelines for the responsible use of antimicrobials. Importantly, with global concerns about the use of antibiotics in food production animals, Aivlosin® is administered under the control of veterinarians, available by prescription only and has low, highly effective therapeutic dose rates, a short treatment duration and a zero day drug withholding period.

Peter Lawrence, Chairman of ECO, commented “We are extremely pleased to receive this marketing authorisation for Aivlosin® in Vietnam which is the largest pork producing country in Southeast Asia and look forward to receiving an approval for commercial layers in the future.”

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

Contacts:

ECO Animal Health Group plc

Peter Lawrence       020 8336 6190
Marc Loomes 020 8447 6906
Spiro Financial
Anthony Spiro 020 8336 6196
N+1 Singer (Nominated Adviser) 020 7496 3000
Mark Taylor, Brough Ransom
Peel Hunt LLP (Joint Broker)
James Steel, Dr Christopher Golden 020 7418 8900
 


a d v e r t i s e m e n t